Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MYMX MYMETICS CORPORATION

0.0340.0000.00%
Trading Session 09/26 12:03 ET
High
0.034
Open
0.034
Turnover
680.00
Low
0.034
Pre Close
0.034
Volume
20.00K
Market Cap
10.33M
P/E(TTM)
Loss
52wk High
0.115
Shares
303.76M
P/E(Static)
Loss
52wk Low
0.025
Float Cap
4.73M
Bid/Ask %
0.00%
Historical High
0.120
Shs Float
139.17M
Volume Ratio
0.51
Historical Low
0.025
Dividend TTM
--
Div Yield TTM
--
P/B
-0.17
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
0.00%
Avg Price
0.034
Lot Size
1
Float Cap
4.73M
Bid/Ask %
0.00%
Historical High
0.120
Shs Float
139.17M
Volume Ratio
0.51
Historical Low
0.025
Dividend TTM
--
P/B
-0.17
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
0.00%
Avg Price
0.034
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Mymetics Corp. operates as a vaccine company. The firm focuses on the research and development of next generation vaccines for infectious and life disabling diseases. It has several vaccine candidates in pipeline: HIV-1/AIDS and Covid-19. Its vaccines for infectious diseases are designed to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense in combination with humoral and cellular immune responses as a second-line defense, which, for some pathogens, may be essential for the development of an effective prophylactic vaccine. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...